|
04/11/2024
|
07:00
|
Encouraging New Product Development Pipeline
|
RNS
|
|
31/10/2024
|
07:00
|
Total Voting Rights
|
RNS
|
|
07/10/2024
|
07:00
|
Further milestone payment triggered post US launch
|
RNS
|
|
01/10/2024
|
07:00
|
Total Voting Rights
|
RNS
|
|
13/09/2024
|
07:00
|
Directors’ / PDMR Dealing
|
RNS
|
|
11/09/2024
|
17:43
|
Trinity Delta research note & consensus forecasts
|
RNS
|
|
10/09/2024
|
07:00
|
Futura Medical - Interim Results 2024
|
RNS
|
|
02/09/2024
|
10:47
|
Update on US Launch
|
RNS
|
|
02/09/2024
|
07:00
|
Update on US launch
|
RNS
|
|
19/08/2024
|
07:00
|
Notice of Results
|
RNS
|
|
01/08/2024
|
07:05
|
Update on US launch
|
RNS
|
|
01/07/2024
|
14:13
|
Total Voting Rights
|
RNS
|
|
01/07/2024
|
07:00
|
Nominated Adviser and Joint Broker
|
RNS
|
|
20/06/2024
|
16:12
|
Result of AGM
|
RNS
|
|
20/06/2024
|
07:00
|
AGM Statement
|
RNS
|
|
31/05/2024
|
07:00
|
Block Listing Six Monthly Review
|
RNS
|
|
24/05/2024
|
07:00
|
Notice of AGM and availability of Annual Report
|
RNS
|
|
29/04/2024
|
07:00
|
Directors’ / PDMR Dealing and Grant of Options
|
RNS
|
|
10/04/2024
|
07:00
|
Results for the Year ended 31 December 2023
|
RNS
|
|
25/03/2024
|
07:00
|
Notice of Results and Investor Presentation
|
RNS
|
|
06/02/2024
|
07:01
|
Trading Update
|
RNS
|
|
06/02/2024
|
07:00
|
Appointment of Joint Corporate Broker
|
RNS
|
|
17/01/2024
|
07:00
|
Remuneration of Non-Exec Directors & Voting Rights
|
RNS
|
|
17/01/2024
|
07:00
|
Director/PDMR Dealing
|
RNS
|
|
15/01/2024
|
07:00
|
Futura Medical extends collaboration with Cooper
|
RNS
|
|
09/01/2024
|
07:00
|
Appointment of Roy Davis as Non-Executive Director
|
RNS
|
|
30/11/2023
|
15:10
|
Total Voting Rights
|
RNS
|
|
30/11/2023
|
15:10
|
Block Listing Six Monthly Return
|
RNS
|
|
07/11/2023
|
07:00
|
Futura expands partnership with M8 Pharmaceuticals
|
RNS
|
|
31/10/2023
|
07:00
|
Block Listing Application and Total Voting Rights
|
RNS
|
|
10/10/2023
|
07:00
|
Directors’/PDMR Dealing and Grant of Options
|
RNS
|
|
02/10/2023
|
07:00
|
European Patent Granted for MED3000 until 2040
|
RNS
|
|
18/09/2023
|
07:00
|
Futura Medical - Interim Results 2023
|
RNS
|
|
18/08/2023
|
07:00
|
Futura Medical - Notice of Interim Results
|
RNS
|
|
31/07/2023
|
07:00
|
Futura Medical - Total Voting Rights
|
RNS
|
|
18/07/2023
|
11:04
|
Board Change
|
RNS
|
|
17/07/2023
|
07:00
|
Futura/Haleon Enter US Commercialisation Agreement
|
RNS
|
|
30/06/2023
|
07:00
|
Futura Medical - Total Voting Rights
|
RNS
|
|
22/06/2023
|
15:19
|
Futura Medical Annual General Meeting Results
|
RNS
|
|
22/06/2023
|
07:00
|
Futura Medical AGM Statement
|
RNS
|
|
19/06/2023
|
10:25
|
Correction - TR-1: Notification of major holdings
|
RNS
|
|
16/06/2023
|
16:05
|
TR-1: Notification of major holdings
|
RNS
|
|
12/06/2023
|
08:23
|
Exercise of Warrants
|
RNS
|
|
12/06/2023
|
07:00
|
MED3000 Granted US FDA Approval for OTC Sale
|
RNS
|
|
08/06/2023
|
07:00
|
Futura Medical Announces Investor Seminar
|
RNS
|
|
31/05/2023
|
07:00
|
Block Listing Six Monthly Return
|
RNS
|
|
26/05/2023
|
07:00
|
Notice of AGM and availability of Annual Report
|
RNS
|
|
24/04/2023
|
07:00
|
TR-1: Notification of major holdings
|
RNS
|
|
18/04/2023
|
07:00
|
MED3000, Eroxon® UK Launch
|
RNS
|
|
06/04/2023
|
11:03
|
Directors' / PDMR Dealing and Grant of Options
|
RNS
|